The biology of malaria parasites: Report of a WHO Scientific Group. WHO Technical Report Series, 1987.
Essential Malariology. L.J. Bruce-Chwatt Heinemann Medical Books,1980.
Coordination of antimalarial activities in South East Europe: Report of a WHO meeting, 1980.
The role and participation of european countries in the fight against malaria in the world: Report on a conference, WHO, Copenhagen, 1980.
A synopsis of infectious and tropical diseases. A.W. Woodruff, S.G. Wright, John Wright, Bristol,1987.
Weathersby, A.B. and McCroddan, D. M. The effects of parabiotic twinning of susceptible and refractory mosquitoes on the development of P. gallinaceum. Journal of parasitology 68: 1081-1084, 1982.
Frizzi et al. Genetic studies on mechanisms influencing the susceptibility of anopheline mosquitoes to Plasmodium infection. Mosquito News, 35 , 1975.
Mons, B. Synchronised erythrocytic schizogony and gametogenesis of P. berghei in vivo and in vitro. Parasitology 91: 423-430, 1985.
Carter, R. and Gwadz, R. Infectiousness and gamete immunisation in malaria, In Kreier, J P ed. malaria, Vol 3, New York Academic Press , 1980.
Melhorn H et al. The formation of ookinates and oocysts in P. gallinaceum and considerations on the phylogenetic relations between haemosporidia, proplasmodia and other Coccidia, Prostologica, 16, 1980.
Vanderberg, J.P., Development of infectivity by the P. berghei sporozoite, Journal of Parasitology, 61, 1980.
Schulman, S. et al, P. berghei and P. knowlesi: serum binding to sporozoites. Experimental Parasitology, 49: 420-429, 1980.
A Colour Atlas of Tropical Medicine and Parasitology. 4th Ed., W. Peters and H.M. Gilles, Mosby-Wolfe, 1995.
Management of severe and complicated malaria: a practical handbook. WHO, Geneva. 1991.
Vector control for malaria and mosquito borne diseases, report of a WHO study group, WHO Geneva, 1995.
Zucker JR, Campbell CC. Smear negative cerebral malaria due to mefloquine resistant P. falciparum acquired in the Amazon. J. Inf. Dis. 166: 1458-1459, 1992.
F. O. Terkuile et al. High dose mefloquine in the treatment of MDR falciparum malaria. J. Inf. Dis. 166: 1393-1400, 1992.
In vivo response of falciparum malaria to chloroquine in Southern Thailand, Kevin Kain et al. J. Inf. Dis. 170: 1994.
Clinical response and susceptibility in vitro of P. vivax to the standard regimen of chloroquine in Thailand, Transactions of the Royal Society of tropical medicine and Hygeine 89: 426, 1995.
Wernsdorfer W. H. Drug resistant malaria, Endeavour, New series, 8, 1979.
Yamanda K.A. and Sherman I.W.P. Cophurae - composition and properties of hemozoin, the malaria pigment. Experimental parasitology, 48, 1979.
Wernsdorfer, W. H. and Trigg P. I. Primaquine pharmacokinetics, metabolism, toxicity and activity. Report of a meeting of the scientific working group on chemotherapy for malaria. New York, WHO. 1984.
Merhli B. and Peters W.A., A comparison of 2 different methods for the selection of primaquine resistance in P. berghei. Annals of tropical medicine and parasitology 70: 1976.
Ferone, R. Dihydrofolate reductase from pyrimethamine resistant P. berghei. JBC 245: 1970.
Eckman et al, Host heme catabolism in drug resistant and drug sensitive malaria. Journal of laboratory and clinical medicine 90: 1977.
Fitch C. D. Mode of action of antimalarial drugs in: Malaria and the red cell, CIBA Foundation Symposium 94: 1983.
Weekly epidemiological record, WHO Geneva, 9th February 1996.
Malaria control in a nutshell, International Development Research Centre, December 1995.
Medicine digest, Vol 20 Nr. 3, May/June 1994.
Medicine digest, Malaria prophylaxis, D. J. Bradley and R. H. Behrens 70: 1994.
© MicrobiologyBytes 2007.